ESC 365 - Pharmacotherapy to reduce weight in patients with HFpEF and obesity: what is the latest evidence?

ESC Professional Premium Access

Pharmacotherapy to reduce weight in patients with HFpEF and obesity: what is the latest evidence?

Session: Weight loss as a therapeutic target in HFpEF: dawn of a new era?

Topic: Chronic Heart Failure

Speaker: Doctor M. Kosiborod (Kansas City, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

4 more presentations in this session

Fat accumulation in the musculature in HFpEF: role for exercise intolerance?

Speaker: Professor M. Haykowsky (Edmonton, CA)

Caloric restriction and structured exercise programmes in HFpEF: do they improve symptoms and functional status?

Speaker: Doctor M. Lee (Glasgow, GB)

Bariatric surgery to manage obesity in patients with HFpEF

Speaker: Professor D. Dicker (Petah Tikva, IL)

Weight loss as a therapeutic target in HFpEF: dawn of a new era? - discussion

Access the full session

Weight loss as a therapeutic target in HFpEF: dawn of a new era?

Speakers: Doctor M. Kosiborod, Professor M. Haykowsky, Doctor M. Lee, Professor D. Dicker

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources